20:06:53:43.  Review of information by independent review organization for experimental or investigational treatment reviews. Each clinical reviewer selected pursuant to §§ 20:06:53:39 to 20:06:53:41, inclusive, shall review all of the information and documents received pursuant to § 20:06:53:42 and any other information submitted in writing by the covered person or the covered person's authorized representative pursuant to § 20:06:53:39. Upon receipt of any information submitted by the covered person or the covered person's authorized representative pursuant to § 20:06:53:39, within one business day after the receipt of the information, the assigned independent review organization shall forward the information to the health carrier.

          Source: 37 SDR 48, effective September 22, 2010; 37 SDR 241, effective July 1, 2011.

          General Authority: SDCL 58-17-87, 58-17H-49, 58-17I-16, 58-18-79.

          Law Implemented: SDCL 58-17-87, 58-18-79.